Libertas Capital Group PLC
02 August 2006


For Immediate Release                                             2 August 2006



                           LIBERTAS CAPITAL GROUP plc

                              SENIOR APPOINTMENTS

                   Libertas Capital expands its UK operations



Aim quoted financial services firm, Libertas Capital Group plc (AIM:LBR),
announces that Andrew Raca and Claire Noyce have joined the firm.  Andrew Raca
joins as a Managing Director within the Corporate Finance division.  He was
previously at the stockbroker Arden Partners where he spent three years as the
Corporate Finance Director in their Birmingham office.  He has over 18 years
experience in corporate finance in industrial, investment banking and broking
environments.


Claire Noyce joins as a Director in the Equity sales division from Nomura's
number one ranked biotech team where she specialised in Life science and small
cap equities. Claire has almost ten years experience in the Life science sector,
and has worked as a Pharmaceuticals research analyst at Lazard and in healthcare
consultancy at a number of other institutions.


Henry Okereke, Chief Executive Officer, commented "Claire and Andrew's
recruitment marks a further step in the growth of our securities and investment
banking business as we continue to expand our operations in both the UK and
overseas"





For further information please contact:

Libertas Capital Group plc                         +44 (0)20 7569 9650
Jakob Kinde, Executive Chairman
Henry Okereke, Chief Executive

Buchanan Communications                            +44 (0)20 7466 5000
Charles Ryland / Mary-Jane Johnson

Notes to Editors

About Libertas Capital Group plc

Libertas Capital is a UK-based financial services firm offering its clients a
full range of dedicated independent  Corporate Finance Advisory, Research and
Distribution services.

Corporate Finance services include advice on M&A, public and private fund
raising, private equity encompassing  development capital, MBOs and MBIs,
valuation and exit strategy. In the Securities business Libertas Capital offers 
research to corporate and institutional clients, via Equity Growth Research and
Libertas Capital Research, over a  global distribution network. Libertas Capital
is focused on the small to mid cap market in the UK, Northern Europe, the 
Nordic region, the US and Asia where the Group has gained widespread experience
and developed strong relationships.

Libertas Capital concentrates primarily on growth companies across a number of
industry sectors with a particular focus  on environmental sciences, natural
resources, technology (software and business services) and medical technology.





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
NRAEANPAEAPKEEE